Dr. David Schwartz of Innovative Science Solutions will be presenting at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom.
Dr. David Schwartz of Innovative Science Solutions will be presenting at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. The IADC meeting is scheduled for Monday, July 06, 2020 – Friday, July 10, 2020 and Dr. Schwartz’s panel will be presenting on Wednesday July 8 at 3:30-5:00pm CDT. If interested, follow this link to register: https://www.iadclaw.org/events/2020-virtual-annual-meeting/
With the advent of inexpensive direct-to-consumer DNA-testing kit services on the market, personal genomics usage has exploded. Millions of people have submitted their DNA samples to genetic testing companies in order to gain insights into ancestry and risk factors for genetic diseases. As a result, commercial genetic testing companies have collected extensive databases of DNA information. This wealth of data may be shared with law enforcement and be the subject of civil discovery requests. Law enforcement’s own ability to conduct increased genetic testing and analyze those results to solve crimes has also greatly improved over the years. We will discuss how genetic testing results are being used in courtrooms throughout the country and even the world, and how you might be able to use genetic testing in your trials.
Speakers: Scott Elder, Alston & Bird, Atlanta, Georgia USA; Joshua D. Lee, Riley Safer Holmes & Cancila LLP, Chicago, Illinois USA; David H. Schwartz, PhD, Innovative Science Solutions, Inc., Morristown, New Jersey USA
Fill out the form below and we'll follow up soon.
On Wednesday July 8, 2020, Dr. David Schwartz of Innovative Science Solutions presented at the IADC 2020 Virtual Annual Meeting on a panel titled The Use of Genetic Testing in the Courtroom. A complimentary copy of the panel presentation is now available for download. Read more
Plaintiff experts having been asserting for decades that all mesotheliomas must be linked to some asbestos exposure. Indeed, this has led to the erroneous (but widespread) view that mesothelioma is a signature disease, only caused by asbestos exposure. Read more
The ToxicoGenomica team has brought genomic causation analysis into over 30 cancer cases for defendants in cases involving benzene, radiation, and asbestos (see here for a description of five of the older cases). Read more
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us